Prevention of Bisphosphonate-Related Osteonecrosis of the Jaws in Patients with Prostate Cancer Treated with Zoledronic acid – a prospective study over 6 years
Conclusions Preventive oral and maxillofacial treatment before bisphosphonate application combined with 3-monthly dental follow-ups significantly reduces the occurrence and risk of BRONJ in PC patients. Therefore this approach should be implemented in the specific treatment algorithms.
Source: Journal of Cranio Maxillofacial Surgery - Category: ENT & OMF Source Type: research
More News: Cancer | Cancer & Oncology | Dentistry | ENT & OMF | Nutrition | Oral Cancer | Prostate Cancer | Reclast | Study | Zometa